Development of quantitative receptor-ligand binding assay for use as a tool to estimate immune responses against plasmodium vivax duffy binding protein region II

Journal of Immunoassay and Immunochemistry

Volumn 33, Issue 4, 2012, Pages 403-413

  Shakri, Ahmad Rushdi ^a,b   Rizvi, M Moshahid A ^b   Chitnis, Chetan E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

binding assay; Duffy antigen; Duffy binding protein; inhibitory antibodies; malaria vaccine; Plasmodium vivax

Indexed keywords

DUFFY BINDING PROTEIN; LIGAND; PLASMODIUM VIVAX DUFFY BINDING PROTEIN REGION II; RECEPTOR; RECOMBINANT PLASMODIUM VIVAX DUFFY BINDING PROTEIN REGION II; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CONTROLLED STUDY; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOASSAY; IN VITRO STUDY; LIGAND BINDING; MOUSE; NONHUMAN; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECEPTOR BINDING; SERUM;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, PROTOZOAN; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, PROTOZOAN; BINDING SITES; CELLS, CULTURED; HEK293 CELLS; HUMANS; IMMUNE SERA; LIGANDS; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; RABBITS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS;

EID: 84866431758     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2012.659781     Document Type: Article

References (13)

1. Hollingdale, M. R.; Nardin, E. H.; Tharavanij, S.; Schwartz, A. L.; Nussenwieg, R. H. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells: An in vitro assay of protective antibodies. J. Immunol. 1984, 132, 909-913. (Pubitemid 14189116)
2. Sattabongkot, J.; Yimamnuaychoke, N.; Leelaudomlipi, S.; Rasameesoraj, M.; Jenwithisuk, R.; Coleman, R. E.; Udomsangpetch, R.; Cui, L.; Brewer, T. G. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am. J. Trop. Med. Hyg. 2006, 74(5), 708-715. (Pubitemid 46774383)
3. Crater, R. Transmission blocking malaria vaccines. Vaccine 2001, 19, 2309-2314.
4. Horuk, R.; Chitnis, C. E.; Darbonne, W. C.; Colby, T. J.; Rybicki, A.; Hadley, T. J.; Miller, L. H. A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor. Science 1993, 261(5125), 1182-1184. (Pubitemid 23300887)
5. Miller, L. H.; Mason, S. J.; Clyde, D. F.; McGinnis, M. H. The resistance factor to Plasmodium vivax in blacks: The Duffy blood-group genotype, FyFy. N. Engl. J. Med. 1976, 295(6), 302-304.
6. Chitnis, C. E.; Miller, L. H. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 1994, 180(2), 497-506. (Pubitemid 24224126)
7. Chitnis, C. E.; Chaudhuri, A.; Horuk, R.; Pogo, A. O.; Miller, L. H. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J. Exp. Med. 1996, 184(4), 1531-1536. (Pubitemid 26354709)
8. Moreno, A.; Caro-Aguilar, I.; Yazdani, S. S.; Shakri, A. R.; Lapp, S.; Strobert, E.; McClure, H.; Chitnis, C. E.; Galinski, M. R. Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques. Vaccine 2008, 26(34), 4338-4344.
9. King, C. L.; Michon, P.; Shakri, A. R.; Marcotty, A.; Stanisic, D.; Zimmerman, P. A.; Cole-Tobian, J. L.; Mueller, I.; Chitnis, C. E. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(24), 8363-8368. (Pubitemid 351904761)
10. Pico de Coana, Y.; Rodriguez, J.; Guerrero, E.; Barrero, C.; Rodriguez, R.; Mendoza, M.; Patarroyo, M. A. A highly infective Plasmodium vivax strain adapted to Aotus monkeys: Quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development. Vaccine 2003, 21(25-26), 3930-3937. (Pubitemid 37338220)
11. de Brevern, A. G.; Wong, H., Tournamille, C.; Colin, Y.; Le Van Kim, C.; Etchebest, C. A. Structural model of a seven-transmembrane helix receptor: the Duffy antigen=receptor for chemokine (DARC). Biochim. Biophys. Acta 2005, 1724(3), 288-306. (Pubitemid 41080037)
12. Choe, H.; Moore, M. J.; Owens, C. M.; Wright, P. L.; Vasilieva, N.; Li, W.; Singh, A. P.; Shakri, R.; Chitnis, C. E.; Farzan, M. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen=receptor for chemokines (DARC). Mol. Microbiol. 2005, 55(5), 1413-1422. (Pubitemid 40342069)
13. Singh, S.; Pandey, K.; Chattopadhayay, R.; Yazdani, S. S.; Lynn, A.; Bharadwaj, A.; Ranjan, A.; Chitnis, C. Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein. J. Biol. Chem. 2001, 276(20), 17111-17116.